Stryker Corporation has just absorbed its worst single-day drop in months, with Q3 results delivering a reality check that the analyst community was quick to reprice. The stock fell 6.4% on October 30 to $291.86, capping a week down 5%. The earnings print confirmed what bears had been warning about: cyber-related supply disruptions in Peripheral Vascular are running longer than…
SYK Canaccord Genuity downgrades to Hold from Buy, cuts price target 22% to $300 as supply disruptions and demand softness persist into year-end.
Key data as of 3 Nov 2026
SYK Canaccord Genuity downgrades to Hold from Buy, cuts price target 22% to $300 as supply disruptions and demand softness persist into year-end.
SYK short interest fell 23.6% over one week to 1.41% of float, driven by a sharp unwinding from Oct 8 through Oct 9 when positions dropped from 7.1M shares to 5.3M.
6 Short Interest updates in 30 days
Stryker enters the final day of September with a paradox at its core: the stock is up 1.3% on the week to $278.77, yet analysts have spent the past three weeks slashing price targets. The gap between where the shares…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SYK — free to start on ORTEX.
Sign up for free →Open SYK on ORTEX